内皮-介质细胞过渡的分子机制及其在脑血管疾病中的病理生理特征
Huimin Jiang1, Yifan Zhou1, Weiyue Zhang2
1Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Ministry of Science and Technology, Capital Medical University, Beijing, 100069, China.
Cell & bioscience
|April 19, 2025
概括
内皮细胞-介质细胞过渡 (EndMT) 涉及内皮细胞 (ECs) 转变为介质细胞,影响心血管和脑血管疾病. 向EndMT为病理条件提供了潜在的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 细胞生物学 细胞生物学
- 病理生理学 病理生理学
背景情况:
- 内皮-介质细胞过渡 (EndMT) 是上皮-介质细胞过渡 (EMT) 的一个亚型.
- 末端瘤治疗涉及内皮细胞 (ECs) 转化为介质细胞,改变其特征.
- 虽然EndMT对心血管发育至关重要,但它也与心血管疾病有关.
研究的目的:
- 在脑血管疾病中提供EndMT的全面概述.
- 讨论EndMT发生的异质性及其调节因素.
- 分析在病理条件下针对EndMT的治疗潜力.
主要方法:
- 文献综述和对EndMT现有研究的综合.
- 分析EndMT在生理和病理状态,特别是脑血管疾病中的作用.
- 评估EndMT作为潜在的治疗点.
主要成果:
- 在心血管健康和疾病中,EndMT扮演着双重角色.
- 关于EndMT在脑血管疾病中的作用存在重大知识差距.
- 末端MT的发生呈异质性,并受到各种因素的调节.
结论:
- 在心血管和脑血管病理中,EndMT是一个关键过程.
- 了解EndMT的监管机制是开发新疗法的关键.
- 准EndMT为脑血管疾病提供了一个有前途的治疗途径.
相关概念视频
The Blood-brain Barrier
46.3K
Overview
46.3K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.0K
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K


